AGP Picks
View all

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on August 27, 2026

Edible Garden Awarded New Target Fresh Herb Program for Peak Holiday Season
Biomerica Announces $2.23 Million Financing 
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
BranchOut Food Inc. Announces $2.79 Million Underwritten Public Offering
Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
BranchOut Secures Approximately $750,000 in Initial Orders for New Front-of-Club Multipack Product Line and Dried Cheesecake Bites with Nation's Largest Warehouse Club Retailer
Alvotech to present at upcoming investor conferences in September
Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
Artelo Biosciences Announces Reverse Stock Split
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
Entera to Participate in Upcoming Fall Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.